Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Niagen Bioscience (NAGE) Return on Capital Employed: 2011-2025

Historic Return on Capital Employed for Niagen Bioscience (NAGE) over the last 7 years, with Sep 2025 value amounting to 0.27%.

  • Niagen Bioscience's Return on Capital Employed rose 26.00% to 0.27% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.27%, marking a year-over-year increase of 26.00%. This contributed to the annual value of 0.18% for FY2024, which is 34.00% up from last year.
  • Latest data reveals that Niagen Bioscience reported Return on Capital Employed of 0.27% as of Q3 2025, which was up 2.93% from 0.26% recorded in Q2 2025.
  • In the past 5 years, Niagen Bioscience's Return on Capital Employed ranged from a high of 0.27% in Q3 2025 and a low of -0.88% during Q2 2022.
  • In the last 3 years, Niagen Bioscience's Return on Capital Employed had a median value of -0.06% in 2024 and averaged -0.02%.
  • In the last 5 years, Niagen Bioscience's Return on Capital Employed decreased by 15bps in 2022 and then soared by 63bps in 2023.
  • Quarterly analysis of 5 years shows Niagen Bioscience's Return on Capital Employed stood at -0.65% in 2021, then climbed by 7bps to -0.58% in 2022, then surged by 42bps to -0.17% in 2023, then surged by 34bps to 0.17% in 2024, then rose by 26bps to 0.27% in 2025.
  • Its Return on Capital Employed was 0.27% in Q3 2025, compared to 0.26% in Q2 2025 and 0.25% in Q1 2025.